---
$id: https://graph.org.ai/products/commodity/51111869
$type: Product
source: UNSPSC
code: "51111869"
title: "Trilostane"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Trilostane

**UNSPSC Code**: 51111869
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a 3-hydroxysteroid dehydrogenase inhibitor and steroidal aromatase inhibitor and anti-adrenal with the molecular formula C20H27NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L0FPV48Q5R, chemically known as 5-alpha-androstane-2-alpha-carbonitrile, 4-alpha,5-epoxy-17-beta-hydroxy-3-oxo- but generally known as trilostane, which bears US NIH Compound Identifier 26163. European Medicines Agency schedules Trilostane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11297MIG. The term TRILOSTANE is an International Non-Proprietary Name. World Health Organization schedules trilostane in its Anatomical Therapeutic Chemical (ATC) Classification. TRILOSTANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trilostane under HS 29372900 and SITC 54153. As of Q4 2014, TRILOSTANE remains the US FDA Preferred Term for this commodity. Trilostane bears US NLM identifiers UMLS ID C0077144 and NCI Concept Code C1263. SMILES: O1C23C(C4C(C5C(CC4)(C(O)CC5)C)CC3)(CC(C(=O)C12)C#N)C.

